CRISPR Technology in Lung Diseases: The Example of Lung Cancer and Cystic Fibrosis

Arch Bronconeumol. 2024 Jul;60(7):397-399. doi: 10.1016/j.arbres.2024.04.017. Epub 2024 Apr 30.

[Article in English, Spanish]

Authors

José M Porcel¹, Mariona Pont², Anabel Sorolla²

Affiliations

¹ Research Group of Cancer Biomarkers, Lleida Institute for Biomedical Research Dr Pifarré Foundation, IRBLleida, Lleida, Spain; Pleural Medicine and Clinical Ultrasound Unit, Department of Internal Medicine, Arnau de Vilanova University Hospital, Lleida, Spain. Electronic address: [email protected].
² Research Group of Cancer Biomarkers, Lleida Institute for Biomedical Research Dr Pifarré Foundation, IRBLleida, Lleida, Spain.

PMID: 38729885
DOI: 10.1016/j.arbres.2024.04.017

No abstract available

Publication types

Editorial

MeSH terms

CRISPR-Cas Systems
Clustered Regularly Interspaced Short Palindromic Repeats
Cystic Fibrosis* / genetics
Gene Editing / methods
Genetic Therapy
Humans
Lung Neoplasms* / genetics